Regeneron Pharmaceuticals 2023 ASH Hematology Investor Event

Regeneron Pharmaceuticals presented clinical and research advances in oncology and hematology at the 2023 American Society of Hematology conference. The presentation covered investigational bispecific antibodies including linvoseltamab for multiple myeloma and odronextamab for lymphomas, alongside classical hematology programs in complement inhibition, Factor XI antibodies, and genetic therapies.